Sign in

CIK 0001680367

  • Non-accelerated filer
  • Smaller reporting company

Shattuck Labs, Inc.

Sign in to watch
Ticker
STTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812575858
Phone
+1 512-900-4690
Business address
500 W. 5TH STREET, AUSTIN, TX, 78701
Former names
Shattuck Labs, Inc.
  1. 4 Open-market buy Director bought 28,330 shares at $3.63 ($102,838)
  2. 4 Open-market buy Director bought 26,283 shares at an average $3.69 ($96,980)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Option exercise Chief Executive Officer acquired 3,926 shares (option exercise)
  5. 4 Open-market buy Director bought 8,000 shares at an average $7.00 ($56,035)
  6. 4 Grant or award Chief Business Officer acquired 21,363 shares (grant or award)
  7. 4 Grant or award Chief Medical Officer acquired 34,738 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 33,325 shares (grant or award)
  9. 4 Option exercise General Counsel acquired 10,000 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Option exercise Chief Financial Officer acquired 20,000 shares (option exercise)
  14. 4 Option exercise Chief Executive Officer acquired 3,926 shares (option exercise)
  15. 4 Open-market sale General Counsel sold 33,000 shares at $19.50 ($643,500)
  16. 4 Option exercise Chief Financial Officer acquired 2,203 shares (option exercise)
  17. 4 Option exercise Chief Medical Officer acquired 4,259 shares (option exercise)
  18. 4 Option exercise Chief Executive Officer acquired 3,926 shares (option exercise)
  19. 4 Open-market sale Chief Financial Officer sold 2,000 shares at $22.13 ($44,263)
  20. 4 Open-market sale General Counsel sold 2,000 shares at $22.18 ($44,367)

Page 7 of 11 · 211 filings